<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08800065910182</udiDi>
    <basicUdiDi>B-08800065910182</basicUdiDi>
    <tradeName>08800065910182</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Ultra Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:05.545Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910175</udiDi>
    <basicUdiDi>B-08800065910175</basicUdiDi>
    <tradeName>08800065910175</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Deep Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:04.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910168</udiDi>
    <basicUdiDi>B-08800065910168</basicUdiDi>
    <tradeName>08800065910168</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Light Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:01.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910151</udiDi>
    <basicUdiDi>B-08800065910151</basicUdiDi>
    <tradeName>08800065910151</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Ultra</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:54.740Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910144</udiDi>
    <basicUdiDi>B-08800065910144</basicUdiDi>
    <tradeName>08800065910144</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:53.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910137</udiDi>
    <basicUdiDi>B-08800065910137</basicUdiDi>
    <tradeName>08800065910137</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Light</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:52.360Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900268</udiDi>
    <basicUdiDi>B-08800065900268</basicUdiDi>
    <tradeName>08800065900268</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:51.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900251</udiDi>
    <basicUdiDi>B-08800065900251</basicUdiDi>
    <tradeName>08800065900251</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT fine</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:45.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900244</udiDi>
    <basicUdiDi>B-08800065900244</basicUdiDi>
    <tradeName>08800065900244</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT Sub-Q</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:43.963Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900237</udiDi>
    <basicUdiDi>B-08800065900237</basicUdiDi>
    <tradeName>08800065900237</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:42.746Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900220</udiDi>
    <basicUdiDi>B-08800065900220</basicUdiDi>
    <tradeName>08800065900220</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Light</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:41.654Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900213</udiDi>
    <basicUdiDi>B-08800065900213</basicUdiDi>
    <tradeName>08800065900213</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>PNfill Ultra</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:34.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900206</udiDi>
    <basicUdiDi>B-08800065900206</basicUdiDi>
    <tradeName>08800065900206</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Deep Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:33.126Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900190</udiDi>
    <basicUdiDi>B-08800065900190</basicUdiDi>
    <tradeName>08800065900190</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Light Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:31.923Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900183</udiDi>
    <basicUdiDi>B-08800065900183</basicUdiDi>
    <tradeName>08800065900183</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Renefil® Ultra Plus</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:30.826Z</lastUpdated>
  </row>
</eudamedExport>